Mount Sinai Health System specialists are expert at diagnosing and treating sarcoidosis, among, only 10 sarcoidosis centers of excellence in the country. Mount Sinai is the only health system in New York City to offer the Kveim-Siltzbach skin test, a noninvasive diagnostic test for sarcoidosis that our specialists are skilled in administering and interpreting. Our physicians are also experienced in administering immunomodulatory medication therapies as alternatives to prednisone. Our specialists evaluate patients for definitive treatments, such as organ transplantation.

Since 1948 when Louis Siltzbach, MD established a sarcoidosis program at Mount Sinai, our service has grown to become the largest in the world, with more than 18,000 patients enrolled to date. Each month nearly 150 new patients register at Mount Sinai to receive care for sarcoidosis.

With thousands of sarcoidosis patients visiting Mount Sinai, we strive to reverse the disease’s progression, manage symptoms, and provide the tools needed to best cope with the disorder depending on the type and severity of each individual case. Through unique diagnostic tests, advanced treatments, and a multidisciplinary approach, we give our patients the resources, support, and care they need to achieve the best possible quality of life. Since our Sarcoidosis Program doctors see a uniquely high volume of patients with the most complex cases, we have developed a rare level of experience and skill in diagnosing and treating the most challenging forms of this disease.

Sarcoidosis is a multi-organ disease, therefore we offer expertise in all aspects of the condition with the help of multidisciplinary teams that include cardiologists, dermatologists, neurologists, nephrologists, pathologists, ophthalmologists, and other specialists who work together to provide the most comprehensive care possible. Every sarcoidosis case is different; therefore, our physicians personalize the most effective treatment plan for each patient.